348 related articles for article (PubMed ID: 33374739)
1. Synergies Radiotherapy-Immunotherapy in Head and Neck Cancers. A New Concept for Radiotherapy Target Volumes-"Immunological Dose Painting".
Mireştean CC; Crişan A; Buzea C; Iancu RI; Iancu DT
Medicina (Kaunas); 2020 Dec; 57(1):. PubMed ID: 33374739
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy and Radiotherapy as an Antitumoral Long-Range Weapon-A Partnership with Unsolved Challenges: Dose, Fractionation, Volumes, Therapeutic Sequence.
Mireștean CC; Iancu RI; Iancu DT
Curr Oncol; 2022 Oct; 29(10):7388-7395. PubMed ID: 36290857
[TBL] [Abstract][Full Text] [Related]
3. Dose painting for re-irradiation of head and neck cancer.
Skjøtskift T; Evensen ME; Furre T; Moan JM; Amdal CD; Bogsrud TV; Malinen E; Dale E
Acta Oncol; 2018 Dec; 57(12):1693-1699. PubMed ID: 30280623
[TBL] [Abstract][Full Text] [Related]
4. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
[TBL] [Abstract][Full Text] [Related]
5. Safety and potential increased risk of toxicity of radiotherapy combined immunotherapy strategy.
Guan H; Zhou Z; Hou X; Zhang F; Zhao J; Hu K
Asia Pac J Clin Oncol; 2023 Feb; 19(1):35-50. PubMed ID: 35538049
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
7. HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial.
Elbers JBW; Gunsch PA; Debets R; Keereweer S; van Meerten E; Zindler J; van Norden Y; Hoogeman MS; Verduijn GM; Kroesen M; Nout RA
BMC Cancer; 2023 Jun; 23(1):541. PubMed ID: 37312053
[TBL] [Abstract][Full Text] [Related]
8. Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer.
Koukourakis IM; Giakzidis AG; Koukourakis MI
Clin Transl Oncol; 2023 Oct; 25(10):3032-3041. PubMed ID: 37059932
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy and Modern Radiotherapy Technique for Older Patients with Locally Advanced Head and Neck Cancer: A Proposed Paradigm by the International Geriatric Radiotherapy Group.
Nguyen NP; Kim L; Thariat J; Baumert BG; Mazibuko T; Gorobets O; Vinh-Hung V; Giap H; Mehmood T; Vincent F; Chi A; Basu T; Loganadane G; Mohammadianpanah M; Karlsson U; Oboite E; Oboite J; Ali A; Page BR
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358703
[TBL] [Abstract][Full Text] [Related]
10. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
[TBL] [Abstract][Full Text] [Related]
11. Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation.
van den Bosch S; Vogel WV; Raaijmakers CP; Dijkema T; Terhaard CHJ; Al-Mamgani A; Kaanders JHAM
Radiother Oncol; 2018 Sep; 128(3):472-478. PubMed ID: 29731161
[TBL] [Abstract][Full Text] [Related]
12. Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.
Choi SH; Chang JS; Choi J; Park SH; Keum KC; Park KR; Lee CG
Anticancer Res; 2018 May; 38(5):3165-3173. PubMed ID: 29715158
[TBL] [Abstract][Full Text] [Related]
13. Overlapping volumes in re-irradiation for head and neck cancer - an important factor for patient selection.
Embring A; Onjukka E; Mercke C; Lax I; Berglund A; Bornedal S; Wennberg B; Friesland S
Radiat Oncol; 2020 Jun; 15(1):147. PubMed ID: 32513217
[TBL] [Abstract][Full Text] [Related]
14. Potential of intensity-modulated radiotherapy to escalate doses to head-and-neck cancers: what is the maximal dose?
Zhou J; Fei D; Wu Q
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):673-82. PubMed ID: 14529771
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
16. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
17. Is anti-PD-1 immunotherapy a means for post-irradiation tumor clearance in head and neck cancer?
Koukourakis IM; Papadimitriou M; Desse D; Zygogianni A; Papadimitriou C; Koukourakis MI
Med Oncol; 2022 Sep; 39(12):186. PubMed ID: 36071248
[TBL] [Abstract][Full Text] [Related]
18. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers.
Mohan R; Wu Q; Manning M; Schmidt-Ullrich R
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):619-30. PubMed ID: 10701741
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.
Łasińska I; Kolenda T; Teresiak A; Lamperska KM; Galus Ł; Mackiewicz J
Anticancer Agents Med Chem; 2019; 19(3):290-303. PubMed ID: 30198439
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience.
Chao KS; Low DA; Perez CA; Purdy JA
Int J Cancer; 2000 Apr; 90(2):92-103. PubMed ID: 10814959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
